Report overview
The global Hemoglobin A1C Testing market size is estimated to be $1.65 billion in 2023, and will reach $3.2 billion by 2032, growing at a CAGR of 7.6% during the forecast period from 2024 to 2032.
This report studies the Hemoglobin A1C Testing market, covering market size for segment by type (Ion-Exchange HPLC, Immunoassay, etc.), by application (Diagnostic Laboratories, Hospitals, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Abbott Laboratories, Siemens Healthineers, Danaher, Bio-Rad Laboratories, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Hemoglobin A1C Testing from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Hemoglobin A1C Testing market.
Leading Players of Hemoglobin A1C Testing including:
Roche
Abbott Laboratories
Siemens Healthineers
Danaher
Bio-Rad Laboratories
EKF Diagnostics
DiaSys Diagnostic Systems
Trinity Biotech
Thermo Fisher Scientific
LumiraDx
ARKRAY
PTS Diagnostics
Transasia Bio-Medicals
Agappe Diagnostics
CPC Diagnostics
Wuxi BioHermes
Market split by Type:
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
Market split by Application:
Diagnostic Laboratories
Hospitals
Others
Market split by Sales Channel:
Direct Channel
Distribution Channel
Market split by Region/Country:
North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
